Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$422M
| $25.7M | ﹤0.01% |
936,182
+7,307
| +0.8% | +$197K |
|
2702
Omnicell
OMCL
$1.69B
| $25.6M | ﹤0.01% |
565,598
-19,762
| -3% | -$723K |
|
|
EVYM
2703
Eaton Vance High Income Municipal ETF
EVYM
$60.4M
| $25.6M | ﹤0.01% |
512,401
+12,000
| +2% | +$599K |
|
|
HI
2704
DELISTED
Hillenbrand
HI
| $25.5M | ﹤0.01% |
804,946
+35,915
| +5% | +$1.11M |
|
2705
DNOW Inc
DNOW
$3.04B
| $25.4M | ﹤0.01% |
1,920,148
+954,998
| +99% | +$13.4M |
|
|
DVAX
2706
DELISTED
Dynavax Technologies
DVAX
| $25.4M | ﹤0.01% |
1,653,993
-4,761
| -0.3% | -$52.4K |
|
2707
Franklin Investment Grade Corporate ETF
FLCO
$558M
| $25.4M | ﹤0.01% |
1,172,120
+26,806
| +2% | +$584K |
|
2708
Progress Software
PRGS
$1.79B
| $25.3M | ﹤0.01% |
589,875
+95,493
| +19% | +$4.16M |
|
2709
Vera Therapeutics
VERA
$2.16B
| $25.3M | ﹤0.01% |
499,665
+225,142
| +82% | +$8M |
|
2710
Republic Bancorp
RBCAA
$1.91B
| $25.2M | ﹤0.01% |
365,717
-8,201
| -2% | -$568K |
|
2711
MannKind Corp
MNKD
$1.24B
| $25.2M | ﹤0.01% |
4,443,922
+593,471
| +15% | +$3.27M |
|
2712
Algonquin Power & Utilities
AQN
$4.44B
| $25.2M | ﹤0.01% |
4,093,676
-41,425
| -1% | -$246K |
|
2713
Vericel Corp
VCEL
$2.29B
| $25.1M | ﹤0.01% |
697,723
+145,962
| +26% | +$5.36M |
|
2714
Iovance Biotherapeutics
IOVA
$3.05B
| $25.1M | ﹤0.01% |
9,191,840
+3,610,277
| +65% | +$8.35M |
|
2715
Atkore
ATKR
$3.17B
| $25.1M | ﹤0.01% |
396,507
+63,513
| +19% | +$4.14M |
|
|
AAMI
2716
Acadian Asset Management
AAMI
$3.27B
| $25M | ﹤0.01% |
532,515
+61,751
| +13% | +$2.85M |
|
2717
Oceaneering
OII
$5.08B
| $25M | ﹤0.01% |
1,041,053
+26,200
| +3% | +$633K |
|
2718
NeoGenomics
NEO
$2.11B
| $25M | ﹤0.01% |
2,126,049
-531,967
| -20% | -$5.74M |
|
2719
Novavax
NVAX
$1.31B
| $25M | ﹤0.01% |
3,717,984
+2,641,540
| +245% | +$19.9M |
|
2720
State Street Ultra Short Term Bond ETF
ULST
$526M
| $24.9M | ﹤0.01% |
615,379
+8,770
| +1% | +$356K |
|
2721
OFG Bancorp
OFG
$2.23B
| $24.9M | ﹤0.01% |
607,542
+77,778
| +15% | +$3.18M |
|
|
EFOR
2722
Everforth Inc
EFOR
$1.34B
| $24.8M | ﹤0.01% |
514,827
-53,039
| -9% | -$2.45M |
|
2723
Urban Edge Properties
UE
$2.75B
| $24.8M | ﹤0.01% |
1,291,579
+150,786
| +13% | +$2.93M |
|
2724
PACS Group
PACS
$7.2B
| $24.8M | ﹤0.01% |
645,581
+147,743
| +30% | +$3.24M |
|
2725
Invesco PHLX Semiconductor ETF
SOXQ
$2.94B
| $24.8M | ﹤0.01% |
444,392
+347,506
| +359% | +$19M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.